Insulin Syringe Units Explained: Reading U-100 Marks for Peptide Dosing
An insulin syringe is the de facto delivery device for almost every subcutaneous peptide in the consumer protocols, and the markings on the barrel are calibrated for a drug class that the syringe was not originally designed for. The number scale reads in units rather than millilitres, the unit definition is keyed to a fixed insulin concentration of one hundred international units per millilitre, and a peptide reconstituted at any other concentration produces a dose in micrograms or milligrams that does not match the unit on the barrel without a deliberate conversion. The framework below covers what a U-100 syringe is, how to read the markings, how to convert a milligram or microgram peptide dose into the corresponding unit volume, and the log fields that make the conversion auditable across a cycle rather than a calculation performed once and forgotten.
What U-100 actually means
The U-100 designation on an insulin syringe describes the concentration the markings were calibrated for: one hundred units of insulin per millilitre of solution, where one unit of insulin is a defined mass of the molecule, set by international convention at roughly 0.0347 milligrams of the biosynthetic human insulin reference standard. The syringe barrel is then printed with markings that read directly in units rather than in millilitres, so a clinician filling a one-millilitre U-100 syringe to the 100-unit mark is filling it with one hundred units of insulin from a standard U-100 vial without having to do any volume math. The number on the barrel and the number on the prescription are the same number, and the unit conversion happens inside the standardised concentration of the vial rather than at the syringe. A peptide vial is not at one hundred units per millilitre of anything; the peptide is at whatever milligram-per-millilitre concentration the reconstitution produced, and the unit marks on the syringe become a volume scale that the user has to translate manually into the dose they actually want.
The barrel scale and what each mark is worth
A standard U-100 insulin syringe comes in three common total volumes: the half-millilitre syringe marked to 50 units in 2-unit increments, the three-tenths-millilitre syringe marked to 30 units in 1-unit increments, and the one-millilitre syringe marked to 100 units in 2-unit increments. The smaller barrels have finer graduations because the same physical distance on the barrel covers fewer units, and a single-unit graduation on the 30-unit syringe corresponds to roughly one-third of the volume of a single-unit graduation on the 100-unit syringe printed at the coarser scale. The implication for peptide dosing is that the choice of barrel size is not a stylistic preference but a precision decision: a small dose on a coarse barrel reads as a large fraction of a single graduation and accumulates rounding error across the cycle, while the same dose on a fine barrel reads cleanly between two adjacent printed marks. The math is the same either way; the readable resolution is not.
The volume one unit represents
A single unit on a U-100 syringe corresponds to one one-hundredth of a millilitre of volume, or 0.01 mL, or 10 microlitres, regardless of which barrel size is in front of the user and regardless of what is actually in the syringe. The unit is a volume measurement printed in the labelling language of insulin, and the peptide protocols inherit that language when they describe a dose as "20 units" or "10 units" without naming the volume directly. A 20-unit dose on a U-100 syringe is therefore 0.2 mL of whatever solution is in the syringe, a 50-unit dose is 0.5 mL, and a 100-unit dose is the full 1 mL of the largest standard barrel. The unit number scales linearly with the volume; the mass of the peptide delivered scales with the concentration the vial was reconstituted at, which is the input the syringe markings do not capture.
The conversion from milligrams to units
The working formula that translates a milligram peptide dose into a unit volume on a U-100 syringe has three inputs: the desired dose in milligrams, the vial reconstitution concentration in milligrams per millilitre, and the U-100 unit-to-millilitre conversion of 100 units per millilitre. The dose in millilitres is the desired milligrams divided by the concentration in milligrams per millilitre, and the dose in units is that millilitre value multiplied by 100. A 0.25 mg dose drawn from a vial reconstituted at 5 mg in 2 mL, for example, is a concentration of 2.5 mg per millilitre, a volume of 0.1 mL, and a unit reading of 10 units on the barrel. The same 0.25 mg dose drawn from a vial reconstituted at 5 mg in 1 mL is a concentration of 5 mg per millilitre, a volume of 0.05 mL, and a unit reading of 5 units. The dose in milligrams is the same in both cases; the unit reading is not. The relevant fact is that the unit number on the syringe is a function of the reconstitution concentration, not a function of the prescription, and a protocol that copies a unit number from one cycle to the next without rechecking the concentration will deliver a different milligram dose than the one it logged. Our reconstitution math primer covers the underlying calculation in more depth, and the live reconstitution calculator performs the conversion against a saved vial profile.
Microgram-scale peptides and the precision problem
A subset of the peptides commonly dosed by U-100 syringe sits in the microgram range rather than the milligram range: the growth hormone secretagogue compounds in the ipamorelin and CJC-1295 family, the bioregulator peptides in the thymosin family, and the melanocortin compounds in the PT-141 family are commonly prescribed in doses of 100 to 300 micrograms rather than 0.25 to 2.5 milligrams. The conversion is the same: the dose in millilitres is the dose in micrograms divided by the concentration in micrograms per millilitre, and the unit reading is that millilitre value multiplied by 100. A 100 mcg dose drawn from a vial reconstituted at 2 mg in 2 mL is a concentration of 1000 mcg per millilitre, a volume of 0.1 mL, and a unit reading of 10 units. A 100 mcg dose drawn from a vial reconstituted at 5 mg in 2 mL is a concentration of 2500 mcg per millilitre, a volume of 0.04 mL, and a unit reading of 4 units on the barrel. The 4-unit reading is at the edge of the readable resolution on a 100-unit barrel, sits cleanly between two marks on a 30-unit barrel, and is the case where the choice of syringe size visibly affects the precision of the delivered dose. The protocols that pair the microgram peptides with the 100-unit barrel are not wrong, but they are running on a coarser scale than the dose deserves.
Where the international unit appears
A third unit appears in some peptide prescriptions: the international unit, or IU, used historically for somatropin and a small set of related compounds whose potency was defined by a biological assay before the molecular structure was standardised. The IU is not the same as the U-100 syringe unit; the IU is a unit of biological activity, and the U-100 syringe unit is a unit of volume. A somatropin prescription written as 2 IU is a mass-equivalent of roughly 0.67 milligrams under the modern 3 IU per milligram conversion, and the syringe volume required to deliver that 0.67 mg from a reconstituted vial follows the standard milligram-to-units formula above. The mistake the protocols sometimes make is reading the 2 IU from the prescription as 2 units on the syringe and filling to the 2-unit mark, which corresponds to 0.02 mL of whatever the vial contains and may bear no relation to the 0.67 mg the prescription intended. The IU is a clinical-potency unit, not a syringe-barrel unit, and a prescription that uses both should be unpacked before the draw rather than during it.
Reading the syringe at the bench
The mechanical practice of reading the unit mark is itself a small source of variance. The plunger has a tapered front face that meets the barrel at a ring rather than a single line, and the reading convention is to align the back edge of the ring with the printed mark rather than the front edge or the centre. The needle hub end of the syringe sometimes has a small dead-space volume the markings do not account for, particularly on syringes with detachable needles; the integrated-needle insulin syringes have a smaller dead space and a cleaner unit-to-volume correspondence than the luer-lock alternatives. The barrel is held vertical during the draw to keep an air bubble at the top rather than along the side, the bubble is expelled with a small flick and a partial push of the plunger, and the unit mark is read after the bubble has cleared rather than before. None of these are unique to peptide dosing; they are the standard practice of injection technique that the peptide protocols inherit from the insulin literature.
What this is not
None of the above is medical advice, a sourcing recommendation, or a substitute for a clinician’s instructions on a specific compound. The framework describes the unit-to-volume-to-mass conversion that makes a dose readable on a U-100 syringe, not the clinical decision to take that dose, and not the prescription that established the milligram or microgram target in the first place. Peptides include prescription and non-prescription compounds in jurisdictions where the regulatory status varies, and the syringe technique and the underlying protocol belong to the user and a qualified clinician. Peptra does not source peptides, does not endorse vendors, and does not provide compound-specific clinical guidance for any individual.
The log fields that keep the conversion auditable
A cycle log that records the reconstitution concentration in milligrams per millilitre, the desired dose in milligrams or micrograms, the calculated volume in millilitres, and the unit reading on the U-100 syringe makes the conversion explicit rather than implicit and lets a later read attribute a marker movement to the dose rather than to an unstated unit assumption. The concentration is the variable that changes when the same compound is reconstituted at a different bacteriostatic-water volume across cycles. The desired dose is the prescription input. The volume is the milligram-per-concentration calculation. The unit reading is the syringe-barrel translation. A log that captures all four lets the same compound run at the same milligram dose across reconstitutions that produced different concentrations, and a log that captures only the unit reading bakes the concentration assumption into a number the user can no longer audit. Our dose-tracking primer covers the broader logging structure, and the conversion is the field set that distinguishes a peptide log from an insulin log.
The practical summary
A U-100 insulin syringe reads in units that correspond to one one-hundredth of a millilitre of volume regardless of what is in the barrel, and the peptide dose in milligrams or micrograms is recovered from that volume by multiplying with the reconstitution concentration. The conversion is straightforward when the concentration is known and dangerous when it is assumed. A 30-unit or 50-unit barrel reads finer than a 100-unit barrel for the same dose and is the standard choice for the microgram-scale peptides. The international unit on a prescription is not the same as the unit on the barrel and should be converted to milligrams before the draw. The log fields that keep the conversion readable across a cycle are the concentration, the desired mass, the calculated volume, and the unit reading, and a cycle that records all four has a structured way of asking whether a marker movement came from the dose or from a hidden change in the concentration.